Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (221-230 of 270) with videos related to

Pageof 27
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2018
Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate CancerMarine F Garrido, Nicolas J-P Martin, Matthieu Bertrand, et al.
Plos One|July 15, 2015
Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 PatientsJames D Brooks, Wei Wei, Sarah Hawley, et al.
European Urology|January 15, 2019
Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate CancerGillian Vandekerkhove, Werner J Struss, Matti Annala, et al.
Cell Communication and Signaling : CCS|September 19, 2019
Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signalingDisharee Nath, Xiang Li, Claudia Mondragon, et al.
The Prostate|May 6, 2015
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancerDean A Troyer, Tamara Jamaspishvili, Wei Wei, et al.
Plos One|November 16, 2016
MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional StudyOkyaz Eminaga, Wei Wei, Sarah J Hawley, et al.
Nature Communications|January 9, 2021
Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancerGillian Vandekerkhove, Jean-Michel Lavoie, Matti Annala, et al.
BMC Urology|September 12, 2018
The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validationVéronique Ouellet, Armen Aprikian, Alain Bergeron, et al.
Communications Biology|February 5, 2025
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancerBengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2007
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor developmentMeritxell Gironella, Mylène Seux, Min-Jue Xie, et al.
Pageof 27

Showing results (221-230 of 270) with videos related to

Sort By:
Pageof 27
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2018
Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate CancerMarine F Garrido, Nicolas J-P Martin, Matthieu Bertrand, et al.
Plos One|July 15, 2015
Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 PatientsJames D Brooks, Wei Wei, Sarah Hawley, et al.
European Urology|January 15, 2019
Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate CancerGillian Vandekerkhove, Werner J Struss, Matti Annala, et al.
Cell Communication and Signaling : CCS|September 19, 2019
Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signalingDisharee Nath, Xiang Li, Claudia Mondragon, et al.
The Prostate|May 6, 2015
A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancerDean A Troyer, Tamara Jamaspishvili, Wei Wei, et al.
Plos One|November 16, 2016
MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional StudyOkyaz Eminaga, Wei Wei, Sarah J Hawley, et al.
Nature Communications|January 9, 2021
Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancerGillian Vandekerkhove, Jean-Michel Lavoie, Matti Annala, et al.
BMC Urology|September 12, 2018
The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validationVéronique Ouellet, Armen Aprikian, Alain Bergeron, et al.
Communications Biology|February 5, 2025
Identification of selective SWI/SNF dependencies in enzalutamide-resistant prostate cancerBengul Gokbayrak, Umut Berkay Altintas, Shreyas Lingadahalli, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 4, 2007
Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor developmentMeritxell Gironella, Mylène Seux, Min-Jue Xie, et al.
Pageof 27